🟢 Viking Therapeutics is trading 5% up today as biotech and broader markets rally

Viking Therapeutics is trading at $27.41, up 5.06%, as the move coincides with a broader biotech and market rally.

• No clear company-specific catalyst emerged for November 4.
• The latest company announcement concerned upcoming investor conferences.
• XBI was up 2.13%, and major U.S. indexes were sharply higher; available evidence points to sector and market sentiment rather than a new Viking-specific event.